body
Measles Cases Hit a 34-Year High: What Families Need to Know Now
With CDC confirming over 2,300 cases this year, the US is on pace for one of its worst measles seasons in a generation.
Body
Weight loss, food noise, training, and the systems that keep consistency alive.
body
56% of Adults Now Qualify for Statins: Should You Take Them?
New 2026 dyslipidemia guidelines instantly made 21.5 million more Americans eligible for cholesterol drugs. We separate the evidence from the hype.
body
Heatwaves and Health: The New Science of Summer Dehydration
Extreme July heat domes are pushing American metabolisms to a breaking point. We break down the data behind the crisis.
body
Stop Chasing 8 Hours: New SLEEP 2026 Data Says Daytime Function Is the Only Metric That Matters
Emerging clinical trials show that optimizing daytime energy and cognitive function is a better health predictor than simply hitting arbitrary sleep duration targets.
Most read
- Willpower Isn't the Problem: What Is Temptation Bundling, and Why It Raised Gym Attendance 51%
- Do You Need a Deload Week? The 50% Rule That Protects Your Gains — and the One Sign That Actually Warrants It
- The 2-Set Strength Rule: How Many Sets per Week for Strength You Actually Need (It's Way Fewer Than You Think)
- What Are Ultra Processed Foods? The 5-Ingredient Rule That Spots Them at the Grocery Store
- The Menopause Cocktail: Why Doctors Are Combining Allergy Meds with HRT
body
Heatwaves and Health: The New Rules of Summer Cardio
Record-breaking heat has made outdoor exercise a calculated risk. Here is how to adapt your routine, read your heart rate, and train safely.
body
The FDA's New Stance on Ultra-Processed Foods: What Changes at the Grocery Store
As the FDA closes in on the first federal definition of ultra-processed foods and phases out petroleum dyes, new research on additives and GLP-1 diets lands at NUTRITION 2026.
body
The GLP-1 Pill Era Starts Now: Oral Drugs, Real Coverage
Orforglipron delivers ~12% weight loss, and Medicare now covers GLP-1 pills for older adults at about $50 a month — here is who qualifies.
body
Up to 40% of GLP-1 Weight Loss Is Lean Mass — Here's the Fix
New studies from Stanford, the ADA, and Cell Press quantify the lean tissue these drugs shed — and resistance training plus protein is the practical fix.
body
The Minimum Viable Wellness Upgrade: Tiny Swaps That Add Years
A Lancet study of 59,000 adults puts hard numbers on the smallest combined sleep, exercise and diet gains linked to years of extra disease-free life.
body
Medicare Made GLP-1s Cheap. Most People Still Quit.
Medicare's GLP-1 Bridge drops Wegovy and Zepbound to about $50/month — but price was never why most people quit. Protein, muscle, the plateau, and the off-ramp decide who actually rebuilds their body.